India News | Press Trust of India | Monday August 15, 2022
Bharat Biotech International Ltd (BBIL) on Monday said it has completed the phase-III and booster dose trials for its intranasal Covid-19 vaccine BBV154, and it has proven to be safe.
www.ndtv.com